Cargando…

Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis

OBJECTIVE: To quantify peripheral nerve lesions in symptomatic and asymptomatic hereditary transthyretin amyloidosis with polyneuropathy (ATTRv‐PNP) by analyzing the magnetization transfer ratio (MTR) of the sciatic nerve, and to test its potential as a novel biomarker for macromolecular changes. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Kollmer, Jennifer, Hegenbart, Ute, Kimmich, Christoph, Hund, Ernst, Purrucker, Jan C., Hayes, John M., Lentz, Stephen I., Sam, Georges, Jende, Johann M. E., Schönland, Stefan O., Bendszus, Martin, Heiland, Sabine, Weiler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261747/
https://www.ncbi.nlm.nih.gov/pubmed/32333729
http://dx.doi.org/10.1002/acn3.51049
_version_ 1783540553650012160
author Kollmer, Jennifer
Hegenbart, Ute
Kimmich, Christoph
Hund, Ernst
Purrucker, Jan C.
Hayes, John M.
Lentz, Stephen I.
Sam, Georges
Jende, Johann M. E.
Schönland, Stefan O.
Bendszus, Martin
Heiland, Sabine
Weiler, Markus
author_facet Kollmer, Jennifer
Hegenbart, Ute
Kimmich, Christoph
Hund, Ernst
Purrucker, Jan C.
Hayes, John M.
Lentz, Stephen I.
Sam, Georges
Jende, Johann M. E.
Schönland, Stefan O.
Bendszus, Martin
Heiland, Sabine
Weiler, Markus
author_sort Kollmer, Jennifer
collection PubMed
description OBJECTIVE: To quantify peripheral nerve lesions in symptomatic and asymptomatic hereditary transthyretin amyloidosis with polyneuropathy (ATTRv‐PNP) by analyzing the magnetization transfer ratio (MTR) of the sciatic nerve, and to test its potential as a novel biomarker for macromolecular changes. METHODS: Twenty‐five patients with symptomatic ATTRv‐PNP, 30 asymptomatic carriers of the mutant transthyretin gene (mutTTR), and 20 age‐/sex‐matched healthy controls prospectively underwent magnetization transfer contrast imaging at 3 Tesla. Two axial three‐dimensional gradient echo sequences with and without an off‐resonance saturation rapid frequency pulse were conducted at the right distal thigh. Sciatic nerve regions of interest were manually drawn on 10 consecutive axial slices in the images without off‐resonance saturation, and then transferred to the corresponding slices that were generated by the sequence with the off‐resonance saturation pulse. Subsequently, the MTR and cross‐sectional area (CSA) of the sciatic nerve were evaluated. Detailed neurologic and electrophysiologic examinations were conducted in all ATTRv‐PNP patients and mutTTR‐carriers. RESULTS: Sciatic nerve MTR and CSA reliably differentiated between ATTRv‐PNP, mutTTR‐carriers, and controls. MTR was lower in ATTRv‐PNP (26.4 ± 0.7; P < 0.0001) and in mutTTR‐carriers (32.6 ± 0.8; P = 0.0005) versus controls (39.4 ± 2.1), and was also lower in ATTRv‐PNP versus mutTTR‐carriers (P = 0.0009). MTR correlated negatively with the NIS‐LL and positively with CMAPs and SNAPs. CSA was higher in ATTRv‐PNP (34.3 ± 1.7 mm(3)) versus mutTTR‐carriers (26.0 ± 1.1 mm(3); P = 0.0005) and versus controls (20.4 ± 1.2 mm(3); P < 0.0001). CSA was also higher in mutTTR‐carriers versus controls. INTERPRETATION: MTR is a novel imaging marker that can quantify macromolecular changes in ATTRv‐PNP and differentiate between symptomatic ATTRv‐PNP and asymptomatic mutTTR‐carriers and correlates with electrophysiology.
format Online
Article
Text
id pubmed-7261747
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72617472020-06-01 Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis Kollmer, Jennifer Hegenbart, Ute Kimmich, Christoph Hund, Ernst Purrucker, Jan C. Hayes, John M. Lentz, Stephen I. Sam, Georges Jende, Johann M. E. Schönland, Stefan O. Bendszus, Martin Heiland, Sabine Weiler, Markus Ann Clin Transl Neurol Research Articles OBJECTIVE: To quantify peripheral nerve lesions in symptomatic and asymptomatic hereditary transthyretin amyloidosis with polyneuropathy (ATTRv‐PNP) by analyzing the magnetization transfer ratio (MTR) of the sciatic nerve, and to test its potential as a novel biomarker for macromolecular changes. METHODS: Twenty‐five patients with symptomatic ATTRv‐PNP, 30 asymptomatic carriers of the mutant transthyretin gene (mutTTR), and 20 age‐/sex‐matched healthy controls prospectively underwent magnetization transfer contrast imaging at 3 Tesla. Two axial three‐dimensional gradient echo sequences with and without an off‐resonance saturation rapid frequency pulse were conducted at the right distal thigh. Sciatic nerve regions of interest were manually drawn on 10 consecutive axial slices in the images without off‐resonance saturation, and then transferred to the corresponding slices that were generated by the sequence with the off‐resonance saturation pulse. Subsequently, the MTR and cross‐sectional area (CSA) of the sciatic nerve were evaluated. Detailed neurologic and electrophysiologic examinations were conducted in all ATTRv‐PNP patients and mutTTR‐carriers. RESULTS: Sciatic nerve MTR and CSA reliably differentiated between ATTRv‐PNP, mutTTR‐carriers, and controls. MTR was lower in ATTRv‐PNP (26.4 ± 0.7; P < 0.0001) and in mutTTR‐carriers (32.6 ± 0.8; P = 0.0005) versus controls (39.4 ± 2.1), and was also lower in ATTRv‐PNP versus mutTTR‐carriers (P = 0.0009). MTR correlated negatively with the NIS‐LL and positively with CMAPs and SNAPs. CSA was higher in ATTRv‐PNP (34.3 ± 1.7 mm(3)) versus mutTTR‐carriers (26.0 ± 1.1 mm(3); P = 0.0005) and versus controls (20.4 ± 1.2 mm(3); P < 0.0001). CSA was also higher in mutTTR‐carriers versus controls. INTERPRETATION: MTR is a novel imaging marker that can quantify macromolecular changes in ATTRv‐PNP and differentiate between symptomatic ATTRv‐PNP and asymptomatic mutTTR‐carriers and correlates with electrophysiology. John Wiley and Sons Inc. 2020-04-25 /pmc/articles/PMC7261747/ /pubmed/32333729 http://dx.doi.org/10.1002/acn3.51049 Text en © 2020 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Kollmer, Jennifer
Hegenbart, Ute
Kimmich, Christoph
Hund, Ernst
Purrucker, Jan C.
Hayes, John M.
Lentz, Stephen I.
Sam, Georges
Jende, Johann M. E.
Schönland, Stefan O.
Bendszus, Martin
Heiland, Sabine
Weiler, Markus
Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
title Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
title_full Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
title_fullStr Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
title_full_unstemmed Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
title_short Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
title_sort magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261747/
https://www.ncbi.nlm.nih.gov/pubmed/32333729
http://dx.doi.org/10.1002/acn3.51049
work_keys_str_mv AT kollmerjennifer magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT hegenbartute magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT kimmichchristoph magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT hundernst magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT purruckerjanc magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT hayesjohnm magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT lentzstepheni magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT samgeorges magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT jendejohannme magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT schonlandstefano magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT bendszusmartin magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT heilandsabine magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis
AT weilermarkus magnetizationtransferratioquantifiespolyneuropathyinhereditarytransthyretinamyloidosis